Graham Capital Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,273
Closed -$2.37M – 1285
2026
Q1
$2.37M Buy
6,273
+4,419
+238% +$1.89M 0.06% 245
2025
Q4
$793K Sell
1,854
-7,671
-81% -$3.34M 0.02% 456
2025
Q3
$4.26M Buy
9,525
+2,083
+28% +$943K 0.07% 130
2025
Q2
$3.62M Buy
7,442
+6,046
+433% +$3.45M 0.05% 198
2025
Q1
$859K Buy
+1,396
New +$793K 0.02% 601
2024
Q4
– Sell
-519
Closed -$312K – 1255
2024
Q3
$312K Buy
+519
New +$294K 0.01% 766
2024
Q2
– Sell
-597
Closed -$383K – 1076
2024
Q1
$383K Buy
597
+250
+72% +$152K 0.01% 696
2023
Q4
$203K Buy
+347
New +$194K ﹤0.01% 839

Other funds holding CHE

Graham Capital Management's CHE Position: Q2 2026 in Review

Graham Capital Management sold out of Chemed (CHE) in Q2 2026, closing a stake of 6,273 shares — an estimated $2.37M sold.

Graham Capital Management first reported a position in CHE in Q4 2023 and held it in 8 quarters. The position peaked at $4.26M in Q3 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Graham Capital Management reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 6,273 Chemed shares in Q2 2026, an estimated $2.37M.
  • Graham Capital Management first reported a position in Chemed in Q4 2023 and held it in 8 quarters.
  • Graham Capital Management's Chemed position peaked at $4.26M in Q3 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.